ClinicalTrials.govpublic full text
Safety and Immunogenicity of PCV20 in Pediatric Patients With Autoimmune Rheumatic Diseases
autoimmune rheumatologic disease, pneumococcal conjugate vaccine, pcv20, autoimmune diseases, pediatric rheumatology, immunogenicity, vaccine safety, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 824933
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.